Excited to be part of this Women in STEM Viepoint 🌟 Huge thanks to @jem.org for the invite - what an inspiring lineup!

Why does selection feel so weak relative to mutation in affinity maturation? A new blog post giving three perspectives, including our new transformer-based model of natural selection on antibodies: matsen.group/general/202...

Dr. Andrea Reboldi from UMass Chan Medical School 🇺🇸 will be presenting his work on "Metabolic regulation of intestinal humoral response". Check his recent study on how receptor signaling controls gut humoral response: pubmed.ncbi.nlm.nih.gov/37714151/ @reboldilab.bsky.social #EMBOBarrierTissues

🚨🦠🔬 Last month to register to the EMBO workshop on Adaptive Immunity in Barrier Tissues. 📍 Where: Basel, Switzerland 📅 When: 26th–29th August 2025 📝 Registration deadline: 30th May 2025 Childcare support & travel grants from @embo.org and @efis-immunology.bsky.social #EMBOBarrierTissues

Kellog, @reboldilab.bsky.social, Vanni et al. reveal that #microbiome-driven tuft cells’ hyperplasia in the colon helps defend against Clostridioides difficile infection. https://buff.ly/3CRIPNy 📘 In Host–Microbe Interactions 2025 👉 https://buff.ly/40XMv8r

Follow our new podcast for more Mucosal Immunology - #MucosalMondays, coming to you the last Monday of every month.

Registration is live!! May 30th deadline for #EMBOTissueImmunity in Basel🇨🇭 (home to Eurocup 2025, Eurovision 2025, Art Basel, world renowned architecture and muuuuuch more!) Be our guest for groundbreaking #immunology discussion, swimming & fun along the Rhine. meetings.embo.org/event/25-bar...

Toronto-based ImmVue Therapeutics Inc. has licensed cancer-fighting technology from UMass Chan Medical School: direc.to/m4zC This partnership was facilitated by BRIDGE Innovation and Business Development at UMass Chan.

Speaker line up for #EMBOTissueImmunity to take place in Basel 🇨🇭 26-29 August 2025. Come join @maurogaya.bsky.social and I for some fantastic #immunology along the Rhine! Please share this invitation - we hope you will join us. Registrations will be open soon.

Microbiome-derived succinate-driven tuft cell hyperplasia in the colon helps defend against Clostridioides difficile infection, providing a pathway through which host/microbe interactions protect against pathogens doi.org/10.1084/jem.... @reboldilab.bsky.social @jexpmed.bsky.social